Stay updated on Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Sign up to get notified when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record is no longer displayed; the page now shows a 403 Forbidden error with a Home link.
    Difference
    21%
    Check dated 2026-10-27T23:05:55.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A sitewide notice about NIH’s terminology transition appears above the page, and the site revision advances from v3.7.1 to v3.7.2. The study record area still shows a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:24:14.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-06T22:25:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, indicating the study record is currently inaccessible. The visible area shows navigation and a footer but no study details.
    Difference
    21%
    Check dated 2026-09-22T23:23:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This reflects a deployment or template update applied to the page.
    Difference
    0.0%
    Check dated 2026-09-15T22:16:49.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, signaling a minor platform or content-management update rather than changes to study data.
    Difference
    0.0%
    Check dated 2026-09-01T19:39:36.000Z thumbnail image

Stay in the know with updates to Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Study of Nivolumab/Bevacizumab/Rucaparib Clinical Trial page.